 Sangamo Therapeutics, Inc. NASDAQ:SGMO Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Louise Wilkie - Investor Relations Sandy Macrae - Chief Executive Officer Rob Schott - Head of Development Jason Fontenot - Chief Scientific Officer Prathyusha Duraibabu - Chief Financial Officer Bettina Cockroft - Chief Medical Officer Conference Call Participants Yanan Zhu - Wells Fargo Nicole Germino - Truist Securities Luca Issi - RBC Capital Kelly OBrien - Stifel Gregory Harrison - Bank of America Kevin Estok - Jefferies Ritu Baral - Cowen Patrick Trucchio - HC Wainwright Operator Thank you for standing by, and welcome to Sangamo First Quarter 2022 Teleconference Call. Operator Instructions Please be advised that todays conference is being recorded. 